Related Experiment Video
Updated: May 24, 2026

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
Published on: November 8, 2024
Platelet activation by Streptococcus sanguinis is accompanied by MAP kinase phosphorylation
Ahmed Y Abdulrehman1, Elke C G Jackson, Archibald McNicol
1Departments of Oral Biology, University of Manitoba, Winnipeg, Manitoba, Canada.
Oral bacteria like S. sanguinis activate platelets, triggering signaling pathways. This study reveals Erk2 MAP kinase involvement in S. sanguinis-induced platelet aggregation and phosphorylation, distinct from p38 MAP kinase.
Area of Science:
- Biochemistry
- Immunology
- Microbiology
Background:
- Infections, particularly oral bacteria, are increasingly linked to atherothrombotic conditions.
- Streptococcus sanguinis (S. sanguinis) strain 2017-78 is known to induce platelet aggregation.
- Platelet activation by S. sanguinis involves complex signaling, including protein phosphorylation and dependence on von Willebrand factor (vWF) and immunoglobulin G (IgG).
Purpose of the Study:
- To investigate the specific role of mitogen-activated protein (MAP) kinases in S. sanguinis strain 2017-78-induced platelet activation.
- To elucidate the signaling pathways downstream of S. sanguinis interaction with platelets, focusing on Erk2 and p38 MAP kinases and cPLA(2).
Main Methods:
- Immunoblotting was employed to analyze the phosphorylation status of MAP kinases (Erk2, p38) and cPLA(2) in platelets stimulated with S. sanguinis strain 2017-78.
- Platelets were pretreated with aspirin or RGDS peptide to assess their effects on signaling events.
- The p38 inhibitor SB203580 was used to evaluate the role of p38 in aggregation and phosphorylation.
Main Results:
- S. sanguinis strain 2017-78 induced a triphasic phosphorylation pattern of Erk2, similar to other signaling proteins, with rephosphorylation dependent on αIIbβ3 integrin engagement.
- Aspirin and RGDS inhibited the Erk2 rephosphorylation phase but not initial phosphorylation or dephosphorylation.
- p38 MAP kinase and cPLA(2) phosphorylation remained elevated upon S. sanguinis stimulation, unaffected by aspirin; however, the p38 inhibitor SB203580 inhibited aggregation without altering p38 or cPLA(2) phosphorylation.
Conclusions:
- The study confirms the activation of Erk2 and p38 MAP kinases, and cPLA(2) in platelets stimulated by S. sanguinis strain 2017-78.
- Erk2 appears to play a role in the cPLA(2) phosphorylation cascade during S. sanguinis-induced platelet activation.
- p38 MAP kinase is involved in S. sanguinis-induced platelet aggregation but not directly in the phosphorylation of p38 or cPLA(2).
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
MAPK Signaling Cascades
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
The JAK-STAT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

